HIV and chronic kidney disease

Clinical Nephrology

Volumn 83, Issue , 2015, Pages S32-S38

  Naicker, Saraladevi ^a   Rahmanian, Sadaf ^a   Kopp, Jeffrey B ^b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Human immunodeficiency virus; Kidney disease; Risk factors; Screening

Indexed keywords

ALBUMIN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; APOLIPOPROTEIN A1; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; CREATININE; FAS ANTIGEN; GLYCOPROTEIN GP 120; HOST FACTOR; HUMAN IMMUNODEFICIENCY VIRUS FUSION INHIBITOR; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 6; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TUMOR NECROSIS FACTOR;

AFRICAN AMERICAN; AGE; ALLELE; ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BASEMENT MEMBRANE; BLACK PERSON; CD4 LYMPHOCYTE COUNT; CELL INFILTRATION; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; CYTOKINE PRODUCTION; DENDRITIC CELL; DIABETES MELLITUS; EARLY DIAGNOSIS; END STAGE RENAL DISEASE; ENVIRONMENTAL FACTOR; EPITHELIUM CELL; FIBROSING ALVEOLITIS; FOCAL GLOMERULOSCLEROSIS; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HEPATITIS B; HEPATITIS C; HIV ASSOCIATED NEPHROPATHY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERGAMMAGLOBULINEMIA; IMMUNE COMPLEX DEPOSITION; IMMUNE COMPLEX DISEASE; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY CELL; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MACROPHAGE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; MICROALBUMINURIA; MISSENSE MUTATION; MIXED INFECTION; MONOCYTE; NONHUMAN; PATHOGENESIS; PERITONEAL DIALYSIS; PHENOTYPE; PRACTICE GUIDELINE; PROTEINURIA; RENAL REPLACEMENT THERAPY; SMOKING CESSATION; SURVIVAL RATE; T LYMPHOCYTE; UPREGULATION; VIRUS LOAD; VIRUS REPLICATION; WEIGHT REDUCTION; COMPLICATION; HEALTH; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC;

GLOBAL HEALTH; HIV; HIV INFECTIONS; HUMANS; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC;

EID: 84924536295     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP83S032     Document Type: Article

References (38)

1. Global report: UNAIDS report on the global AIDS epidemic 2013.
2. Fabian J, Naicker S. HIV and kidney disease in sub-Saharan Africa. Nat Rev Nephrol. 2009; 5: 591-598.
3. Rao TK. Human immunodeficiency virus infection and renal failure. Infect Dis Clin North Am. 2001; 15: 833-850.
4. Levin ML, Palella F, Shah S, Lerma E, Butter J, Kanwar YS. HIV-associated nephropathy occurring before HIV antibody seroconversion. Am J Kidney Dis. 2001; 37: E39.
5. Gerntholtz TE, Goetsch SJ, Katz I. HIV-related nephropathy: a South African perspective. Kidney Int. 2006; 69: 1885-1891.
6. Wearne N, Swanepoel CR, Boulle A, Duffield MS, Rayner BL. The spectrum of renal histologies seen in HIV with outcomes, prognostic indicators and clinical correlations. Nephrol Dial Transplant. 2012; 27: 4109-4118.
7. Conaldi PG, Biancone L, Bottelli A, Wade-Evans A, Racusen LC, Boccellino M, Orlandi V, Serra C, Camussi G, Toniolo A. HIV-1 kills renal tubular epithelial cells in vitro by triggering an apoptotic pathway involving caspase activation and Fas upregulation. J Clin Invest. 1998; 102: 2041-2049.
8. Hatsukari I, Singh P, Hitosugi N, Messmer D, Valderrama E, Teichberg S, Chaung W, Gross E, Schmidtmayerova H, Singhal PC. DEC-205-mediated internalization of HIV-1 results in the establishment of silent infection in renal tubular cells. J Am Soc Nephrol. 2007; 18: 780-787.
9. Kajiyama W, Kopp JB, Marinos NJ, Klotman PE, Dickie P. Glomerulosclerosis and viral gene expression in HIV-transgenic mice: role of nef. Kidney Int. 2000; 58: 1148-1159.
10. Zuo Y, Matsusaka T, Zhong J, Ma J, Ma LJ, Hanna Z, Jolicoeur P, Fogo AB, Ichikawa I. HIV-1 genes vpr and nef synergistically damage podocytes, leading to glomerulosclerosis. J Am Soc Nephrol. 2006; 17: 2832-2843.
11. Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, Bowden DW, Oleksyk T, McKenzie LM, Kajiyama H, Ahuja TS, Berns JS, Briggs W, Cho ME, Dart RA, Kimmel PL, Korbet SM, Michel DM, Mokrzycki MH, Schelling JR, Simon E, et al. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet. 2008; 40: 1175-1184.
12. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, Uscinski Knob AL, Bernhardy AJ, Hicks PJ, Nelson GW, Vanhollebeke B, Winkler CA, Kopp JB, Pays E, Pollak MR. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science. 2010; 329: 841-845.
13. Kopp JB, Nelson GW, Sampath K, Johnson RC, Genovese G, An P, Friedman D, Briggs W, Dart R, Korbet S, Mokrzycki MH, Kimmel PL, Limou S, Ahuja TS, Berns JS, Fryc J, Simon EE, Smith MC, Trachtman H, Michel DM, et al. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol. 2011; 22: 2129-2137.
14. Weiner NJ, Goodman JW, Kimmel PL. The HIVassociated renal diseases: current insight into pathogenesis and treatment. Kidney Int. 2003; 63: 1618-1631.
15. Ross MJ, Fan C, Ross MD, Chu TH, Shi Y, Kaufman L, Zhang W, Klotman ME, Klotman PE. HIV-1 infection initiates an inflammatory cascade in human renal tubular epithelial cells. J Acquir Immune Defic Syndr. 2006; 42: 1-11.
16. Cohen SD, Kimmel PL. Immune complex renal disease and human immunodeficiency virus infection. Semin Nephrol. 2008; 28: 535-544.
17. Lucas GM, Eustace JA, Sozio S, Mentari EK, Appiah KA, Moore RD. Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study. AIDS. 2004; 18: 541-546.
18. USRDS 2012 Annual Data Report http://www. usrds.org/atlas12.aspx; accessed May 10, 2014.
19. Lescure FX, Flateau C, Pacanowski J, Brocheriou I, Rondeau E, Girard PM, Ronco P, Pialoux G, Plaisier E. HIV-associated kidney glomerular diseases: changes with time and HAART. Nephrol Dial Transplant. 2012; 27: 2349-2355.
20. Gupta SK, Eustace JA, Winston JA, Boydstun II, Ahuja TS, Rodriguez RA, Tashima KT, Roland M, Franceschini N, Palella FJ, Lennox JL, Klotman PE, Nachman SA, Hall SD, Szczech LA. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2005; 40: 1559-1585.
21. Szczech LA, Gupta SK, Habash R, Guasch A, Kalayjian R, Appel R, Fields TA, Svetkey LP, Flanagan KH, Klotman PE, Winston JA. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int. 2004; 66: 1145-1152.
22. Fabian J, Naicker S, Goetsch S, Venter WD. The clinical and histological response of HIV-associated kidney disease to antiretroviral therapy in South Africans. Nephrol Dial Transplant. 2013; 28: 1543-1554.
23. Reid A, Stöhr W, Walker AS, Williams IG, Kityo C, Hughes P, Kambugu A, Gilks CF, Mugyenyi P, Munderi P, Hakim J, Gibb DM; Development of Antiretroviral Therapy Trial. Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy. Clin Infect Dis. 2008; 46: 1271-1281.
24. Peters PJ, Moore DM, Mermin J, Brooks JT, Downing R, Were W, Kigozi A, Buchacz K, Weidle PJ. Antiretroviral therapy improves renal function among HIV-infected Ugandans. Kidney Int. 2008; 74: 925-929.
25. Mpondo BC, Kalluvya SE, Peck RN, Kabangila R, Kidenya BR, Ephraim L, Fitzgerald DW, Downs JA. Impact of antiretroviral therapy on renal function among HIV-infected Tanzanian adults: a retrospective cohort study. PLoS ONE. 2014; 9: e89573.
26. Berns JS, Kasbekar N. Highly active antiretroviral therapy and the kidney: an update on antiretroviral medications for nephrologists. Clin J Am Soc Nephrol. 2006; 1: 117-129.
27. Izzedine H, Harris M, Perazella MA. The nephrotoxic effects of HAART. Nat Rev Nephrol. 2009; 5: 563-573.
28. Szczech LA, Grunfeld C, Scherzer R, Canchola JA, van der Horst C, Sidney S, Wohl D, Shlipak MG. Microalbuminuria in HIV infection. AIDS. 2007; 21: 1003-1009.
29. Wyatt CM, Winston JA, Malvestutto CD, Fishbein DA, Barash I, Cohen AJ, Klotman ME, Klotman PE. Chronic kidney disease in HIV infection: an urban epidemic. AIDS. 2007; 21: 2101-2103.
30. Hadigan C, Edwards E, Rosenberg A, Purdy JB, Fleischman E, Howard L, Mican JM, Sampath K, Oyalowo A, Johnson A, Adler A, Rehm C, Smith M, Lai L, Kopp JB. Microalbuminuria in HIV disease. Am J Nephrol. 2013; 37: 443-451.
31. Post FA, Campbell LJ, Hamzah L, Collins L, Jones R, Siwani R, Johnson L, Fisher M, Holt SG, Bhagani S, Frankel AH, Wilkins E, Ainsworth JG, Larbalestier N, Macallan DC, Banerjee D, Baily G, Thuraisingham RC, Donohoe P, Hendry BM, et al. Predictors of renal outcome in HIV-associated nephropathy. Clin Infect Dis. 2008; 46: 1282-1289.
32. Bigé N, Lanternier F, Viard JP, Kamgang P, Daugas E, Elie C, Jidar K, Walker-Combrouze F, Peraldi MN, Isnard-Bagnis C, Servais A, Lortholary O, Noël LH, Bollée G. Presentation of HIV-associated nephropathy and outcome in HAART-treated patients. Nephrol Dial Transplant. 2012; 27: 1114-1121.
33. Fine DM, Wasser WG, Estrella MM, Atta MG, Kuperman M, Shemer R, Rajasekaran A, Tzur S, Racusen LC, Skorecki K. APOL1 risk variants predict histopathology and progression to ESRD in HIV-related kidney disease. J Am Soc Nephrol. 2012; 23: 343-350.
34. Stock PG, Barin B, Murphy B, Hanto D, Diego JM, Light J, Davis C, Blumberg E, Simon D, Subramanian A, Millis JM, Lyon GM, Brayman K, Slakey D, Shapiro R, Melancon J, Jacobson JM, Stosor V, Olson JL, Stablein DM, et al. Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med. 2010; 363: 2004-2014.
35. Ingulli E, Tejani A, Fikrig S, Nicastri A, Chen CK, Pomrantz A. Nephrotic syndrome associated with acquired immunodeficiency syndrome in children. J Pediatr. 1991; 119: 710-716.
36. Tourret J, Tostivint I, Tézenas Du Montcel S, Karie S, Launay-Vacher V, Vigneau C, Bessette C, Deray G, Bagnis C. Antiretroviral drug dosing errors in HIV-infected patients undergoing hemodialysis. Clin Infect Dis. 2007; 45: 779-784.
37. Kalayjian RC. The treatment of HIV-associated nephropathy. Adv Chronic Kidney Dis. 2010; 17: 59-71.
38. Lucas GM, Ross MJ, Stock PG, Shlipak MG, Wyatt CM, Gupta SK, Atta MG, Wools-Kaloustian KK, Pham PA, Bruggeman LA, Lennox JL, Ray PE, Kalayjian RC. Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2014; 59: e96-e138.